Proapoptotic effects of ceranib-2 in combination with radiation therapy on human breast cancer cells
CONCLUSIONS: The study results suggest that co-treatment of human breast adenocarcinoma cells with a ceramidase inhibitor, ceranib-2, and a high dose of radiation of 20 Gy exerted cytotoxicity and apoptosis and might be a solid, potent alternative to current therapy strategies.PMID:38567595 | DOI:10.26355/eurrev_202403_35736
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: F Tu ğrul C Vejselova Sezer H M Kutlu Source Type: research
More News: Adenocarcinoma | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Drugs & Pharmacology | Radiation Therapy | Study